Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Autoimmunity: early-phase trial registry
2 of 3 indexed Autoimmunity trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Autoimmunity: 3 US clinical trials tracked, 2 recruiting.
Autoimmunity is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is HI-Bio, A Biogen Company, running 1 of these trials.
Enrollment posture brief
Registry condition autoimmunity
OPEN 2 | RECR 67% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Autoimmunity lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Autoimmunity on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Autoimmunity is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
NIAID Centralized Sequencing Protocol
National Institute of Allergy and Infectious Diseases (NIAID)
NCT03206099
Autoimmunity After Checkpoint Blockade
Abramson Cancer Center at Penn Medicine
NCT04119713
A Study of Safety and Drug Levels of HIB210 in Healthy Volunteers
HI-Bio, A Biogen Company
NCT05928585
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Autoimmunity records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Autoimmunity trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Autoimmunity page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Autoimmunity trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- HI-Bio, A Biogen Company sponsors the most Autoimmunity trials on record, review their full trial history before evaluating a specific study. See HI-Bio, A Biogen Company's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Autoimmunity condition card totals 3 registered trials; most-linked intervention HIB210; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.